Vaccines book cover

Vaccines

Expert Consult - Online and Print

2013 BMA Medical Book Awards Highly Commended in Public Health!

Apply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice!

Hardbound, 1570 Pages

Published: October 2012

Imprint: Saunders

ISBN: 978-1-4557-0090-5

Reviews

  • "Widely regarded as The Bible for vaccinologists… the book remains the work of reference that every person working in the field of vaccines and those with an interest in infectious diseases should have."

    The Lancet: Infectious Diseases, June 2008

    "For anyone wishing to know everything important about existing vaccines, this book provides an indispensable source of authoritative information."

    Immunology News, February 2009

    "The new foreword by Bill Gates emphasizes the importance of vaccines and the value of this book.  This is the leading reference that covers all aspects of vaccinology.  There are no comparable books available.  In the rapidly evolving field of vaccinology, this new edition is essential."

    - Archana NMI Chatterjee, MD PhD, Creighton University

    5 Star - Doody's Rating, March 2013 


Contents

  • SECTION 1: General aspects of vaccination

    1 A short history of vaccination 1

    2 Vaccine immunology 14

    3 The vaccine industry 33

    4 Vaccine manufacturing 44

    5 Evolution of adjuvants across the centuries 58

    6 Vaccine additives and manufacturing residuals in the United States:

    licensed vaccines 71

    7 Passive immunization 80

    8 General immunization practices 88

    SECTION 2: Licensed vaccines

    9 Adenovirus vaccines 113

    10 Anthrax vaccines 127

    11 Cholera vaccines 141

    12 Diphtheria toxoid 153

    13 Haemophilus influenzae vaccines 167

    14 Hepatitis A vaccines 183

    15 Hepatitis B vaccines 205

    16 Human papillomavirus vaccines 235

    17 Inactivated influenza vaccines 257

    18 Influenza vaccine-live 294

    19 Japanese encephalitis vaccines 312

    20 Measles vaccines 352

    21 Meningococcal vaccines 388

    22 Mumps vaccine 419

    23 Pertussis vaccines . 447

    24 Plague vaccines 493

    25 Pneumococcal conjugate vaccine and pneumococcal common protein vaccines 504

    26 Pneumococcal polysaccharide vaccines 542

    27 Poliovirus vaccine-inactivated . 573

    28 Poliovirus vaccine-live 598

    29 Rabies vaccines .646

    30 Rotavirus vaccines . 669

    31 Rubella vaccine 688

    32 Smallpox and vaccinia 718

    33 Tetanus toxoid 746

    34 Tick-borne encephalitis virus vaccines 773

    35 Tuberculosis vaccines 789

    36 Typhoid fever vaccines 812

    37 Varicella vaccine 837

    38 Yellow fever vaccine 870

    39 Zoster vaccine 969

    40 Combination vaccines 981

    SECTION 3: Vaccines in development and new vaccine strategies

    41 Biodefense and special pathogen vaccines 1008

    42 Therapeutic cancer vaccines 1018

    43 Cytomegalovirus vaccines 1032

    44 Dengue vaccines 1042

    45 Diarrhea caused by bacteria 1052

    46 Ebola vaccine 1060

    47 Epstein-Barr virus vaccines 1068

    48 Hepatitis C vaccines 1074

    49 Hepatitis E vaccines 1085

    50 Herpes simplex virus vaccines 1090

    51 Human immunodeficiency virus vaccines 1097

    52 Lyme disease vaccines 1122

    53 Malaria vaccines 1133

    54 Noninfectious disease vaccines 1138

    55 Respiratory syncytial virus and parainfluenza virus vaccines 1146

    56 Parasitic disease vaccines 1154

    57 Staphylococcus aureus vaccines 1161

    58 Streptococcus group A vaccines 1169

    59 Streptococcus group B vaccines 1176

    60 Technologies for making new vaccines 1182

    61 Alternative vaccine delivery methods 1200

    62 The development of gene-based vectors for immunization 1232

    SECTION 4: Vaccination of special groups

    63 Vaccination of immunocompromised hosts 1243

    64 Vaccination of human immunodeficiency virus-infected persons 1257

    65 Vaccines for international travel 1270

    66 Vaccines for health care personnel 1290

    SECTION 5: Public health and regulatory issues

    67 Immunization in the United States 1310

    68 Immunization in Europe . 1334

    69 Immunization in the Asia-Pacific region 1353

    70 Immunization in developing countries 1369

    71 Community immunity 1395

    72 Economic analyses of vaccine policies 1413

    73 Regulation and testing of vaccines 1427

    74 Regulation of vaccines in Europe 1447

    75 Regulation of vaccines in developing countries 1454

    76 Vaccine safety 1464

    77 Legal issues . 1481

    78 Ethics 1508

Advertisement

advert image